Респираторная медицина. Руководство (в 2-х томах)

Чучалин А. Г.

66.Michaelson ED, Grassman ED, Peters WR.
– Pulmonary mechanics by spectral analysis of forced random noise. J Clin Invest. 1975, 56: 1210-1230.

67.Кирюхина ЛД, Кузнецова ВК, Аганезова ЕС, Яковлева НГ, Каменева МЮ.
– Метод импульсной осциллометрии в диагностике нарушений механики дыхания. Пульмонология. 2000, 2: 31-36.

68.Пашкова ТЛ, Чикина СЮ, Чучалин АГ.
– Импульсная осциллометрия в оценке респираторной механики. Сборник тезисов 15-го Национального конгресса по болезням органов дыхания. Москва, 29 ноября-2 декабря 2005

г. Пульмонология. 2005, приложение: 216 (799).

69.Bohadana AB, Peslin R, Megherbi SE, et al.
– Dose-response slope of forced oscillation and forced expiratory parameters in bronchial challenge testing. Eur Respir J. 1999, 13: 295-300.

70.Schmekel B, Smith HJ.
– The diagnostic capacity of forced oscillation and forced expiration techniques in identifying asthma by isocapnic hyperpnoea of cold air. Eur Respir J. 1997, 10: 2243-2249.

71.Неклюдова ГВ, Черняк АВ.
– Импульсная осциллометрия в оценке провокационного теста. Сборник тезисов 15-го Национального конгресса по болезням органов дыхания. Москва, 29 ноября-2 декабря 2005 г. Пульмонология. 2005, приложение: 213 (785).

72.Goldman MD, Carter R, Klein R, et al.
– Within- and between-day variability of respiratory impedance, using impulse oscillometry in adolescent asthmatics. Pediatr Pulmonol. 2002, 34: 312-319.

73.Vink GR, Arets HG, van der Laag J, et al.
– Impulse oscillometry: A measure for airway obstruction. Pediatr Pulmonol. 2003, 35: 214-219.

74.Johnson BD, Beck KC, Jorge Zeballos R, Weisman IM.
– Advances in Pulmonary Laboratory Testing. Chest. 1999, 116: 1377-1387.

75.Skloot G, Permutt S, Togias A.
– Airway hyperresponsiveness in asthma: a problem of limited smooth muscle relaxation with inspiration. J Clin Invest. 1995, 96: 2393-2403.

76.Lebecque P, Stanescu D.
– Respiratory resistance by the forced oscillation technique in asthmatic children and cystic fibrosis patients. Eur Respir J 1997, 10: 891-895.

77.Pasker HG, Schepers R, Clement J, et al.
– Total respiratory impedance measured by means of the forced oscillation technique in subjects with and without respiratory complaints. Eur Respir J 1996, 9: 131-139.

78.Gibson GJ, Pride NB.
– Lung distensibility: The static pressure-volume curve of the lungs and its use in clinical assessment. Br J Dis Chest. 1976, 70: 143-184.

79.Woolcock AJ, Vincent JN, Macklem PT.
– Frequency dependence of compliance as a test for obstruction in the small airways. J Clin Invest. 1969, 48: 1097-1105.

80.American Thoracic Society. Lung Function Testing: Selection of Reference Values and Interpretative Strategies. Am Rev Respir Dis 1991, 144: 1202-1218.

81.Quanjer PH.
– Standardized Lung Function Testing. Bull Eur Physiopathol. 1983, 19: suppl. 5, 22-27.

82.Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CPM, Gustafsson P, Hankinson J, Jensen R, Johnson DC, MacIntyre N, McKay R, Miller MR, Navajas D, Pedersen OF, Wanger J.
– Interpretative strategies for lung function tests. Eur Respir J. 2005, 26: 948-968.

83.Hankinson JL, Odencratz JR, Fedan KB.
– Spirometric reference values from a sample of the general US population. Am J Respir Crit Care Med. 1999, 159: 179 - 187.

84.Hardie JA, Buist AS, Vollmer WM, Ellingsen I, Bakke PS, Morkve O.
– Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers. Eur Respir J. 2002, 20: 1117 - 1122.

85.Stocks J, Quanjer PH.
– Reference values for residual volume, functional residual capacity and total lung capacity. Eur Respir J. 1995, 8: 492 - 506.

86.McCarthy DS, Craig DB, Cherniak RM - Intraindividual variability in maximal expiratory flow-volume and closing volume in asymptomatic subjects. Am Rev Respir Dis. 1975, 112: 407-411.

87.Wise RA, Connett J, Kurnow K, et al.
– Selection of spirometric measurements in a clinical trial, the Lung Health Study. Am J Respir Crit Care Med. 1995, 151: 675-681.

88.Wang ML, McCabe L, Petsonk EL, et al.
– Weight gain and longitudinal changes in lung function in steel workers. Chest. 1997, 111: 1526-1532.

89.American Thoracic Society. Single breath carbon monoxide diffusing capacity (transfer factor): Recommendations for a standard technique. Am Rev Respir Dis 1987; 136:1299.

90.American Thoracic Society. Single-breath carbon monoxide diffusing capacity (transfer factor): Recommendations for a standard technique 1995 update. Am J Respir Crit Care Med 1995; 152:2185.

91.Morrison, NJ, Abboud, RT, Ramadan, F, et al. Comparison of DLCO and pressure-volume curves in detecting emphysema. Am Rev Respir Dis 1989; 139:1179.

92.Gould, GA, Redpath, AT, Ryan, M, et al. Lung CT density correlates with measurements of airflow limitation and diffusing capacity. Eur Respir J 1991; 4:141.

93.Stewart, RI. Carbon monoxide diffusing capacity in asthmatic patients with mild airflow limitation. Chest 1988; 94:332.

94.DoPico, GA, Wiley, AL Jr, Rao, P, Dickie, HA. Pulmonary reaction in upper mantle radiation therapy for Hodgkin's disease. Chest 1979; 75:688.

95.Luursema, PB, Star-Kroesen, MA, VanDer Mark, THW, et al. Bleomycin-induced changes in the carbon monoxide transfer factor of the lungs and its components. Am Rev Respir Dis 1983; 128:880.

96.Crawford, SW, Pepe, M, Lin, D, et al. Abnormalities of pulmonary function tests after marrow transplantation predict nonrelapse mortality. Am J Respir Crit Care Med 1995; 152:690.

97.Mitchell, DM, Fleming, J, Pinching, AJ, et al. Pulmonary function in human immunodeficiency virus infection. Am Rev Respir Dis 1992; 146:745.

98.Nieman, RB, Fleming, J, Coker, RJ, et al. Reduced carbon monoxide transfer factor (TLCO) in human immunodeficiency virus type I (HIV-I) infection as a predictor for faster progression to AIDS. Thorax 1993; 48:481.